¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"ventricular cell"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
cell interaction
¼¼Æ÷»óÈ£ÀÛ¿ë
cell labeling technique
¼¼Æ÷Ç¥Áö±â¹ý
cell lethality
¼¼Æ÷Ä¡»çÀ²
cell line
¼¼Æ÷ÁÖ, ¼¼Æ÷°è
cell loss
¼¼Æ÷¼Ò½Ç
cell mass
¼¼Æ÷µ¢ÀÌ, ¼¼Æ÷±«
cell membrane
¼¼Æ÷¸·
cell membrane permeability
¼¼Æ÷¸·Åõ°ú¼º
cell organelle
¼¼Æ÷¼Ò±â°ü
cell respiration
¼¼Æ÷È£Èí
cell strain
¼¼Æ÷ÁÖ
cell substitution
¼¼Æ÷´ëü, Ç÷±¸´ëü
cell surface receptor
¼¼Æ÷Ç¥¸é¼ö¿ëü
cell swelling
¼¼Æ÷Á¾Ã¢
cell-associated antibody
¼¼Æ÷¿¬°üÇ×ü
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
cell surface receptor
¼¼Æ÷Ç¥¸é¼ö¿ëü
cell-associated virus
¼¼Æ÷ºÎÂø¹ÙÀÌ·¯½º
cell-mediated cytolysis
¼¼Æ÷¸Å°³¼¼Æ÷¿ëÇØ
cell-mediated cytotoxicity
¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
cell-mediated hypersensitivity
¼¼Æ÷¸Å°³°ú¹Î
cell-mediated immunity
¼¼Æ÷¸Å°³¸é¿ª
cell-mediated reaction
¼¼Æ÷¸Å°³¹ÝÀÀ
cell-mediated response
¼¼Æ÷¸Å°³¹ÝÀÀ
cell-mediated immunodeficiency syndrome
¼¼Æ÷¸Å°³¸é¿ª°áÇÌÁõÈıº
cell-mediated lympholysis test
¼¼Æ÷¸Å°³¸²ÇÁ±¸¿ëÇØ½ÃÇè
centroacinar cell
»ù²Ê¸®Á߽ɼ¼Æ÷
chief cell
À¸¶ä¼¼Æ÷
Chinese hamster ovary cell
Áß±¹ºñ´ÜÅÐÁã³¼Ò¼¼Æ÷
chromaffin cell
ģũ·Ò¼¼Æ÷, Å©·Òģȼ¼Æ÷
chromophilic cell
»ö¼Òµë¼¼Æ÷, È£»ö¼Ò¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
antibody producing cell
Ç×ü»ý»ê¼¼Æ÷
antigen presenting cell
Ç׿øÁ¦½Ã¼¼Æ÷.
antigen reactive cell
Ç׿ø¹ÝÀÀ¼¼Æ÷.
apex of cell
¼¼Æ÷²À´ë±â
apical cell
Á¤(´Ü)¼¼Æ÷(ð¢Ó®á¬øà)
argentaffin chromaffin cell
Å©·Òģȼº ¼¼Æ÷
argyrophil(e) cell
ÀºÄ£È¼º ¼¼Æ÷(ëÞöÑûúàõá¬øà)
arsenical basal cell carcinoma
ºñ¼Ò¼º(Ý÷áÈàõ) ±âÀú¼¼Æ÷¾Ï
arteritis,giant cell of aorta
´ëµ¿¸Æ(ÓÞÔÑØæ)ÀÇ °Å¼¼Æ÷¼º(ËÝá¬øààõ)
free cell
ÀÚÀ¯¼¼Æ÷(í»ë¦á¬øà).
functional cell
±â´É¼¼Æ÷(ѦÒöá¬øà).
funicular cell
ÁÙ¼¼Æ÷, »è¼¼Æ÷(ßãá¬øà).
fusiform cell
¹æÃß¼¼Æ÷
fusiform endothelial cell
¹æÃß³»ÇǼ¼Æ÷
fusiform myoepithelial cell
¹æÃßÇü ±Ù»óÇÇ ¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ventricular preponderance
½É½Ç¼º ¿ìÀ§(ãýãøàõéÐêÈ).
ventricular pressure
³ú½Ç¾Ð(Òàãøäâ).
ventricular presystole
½É½ÇÀü¼öÃà±â(ãýãøîñâ¥õêÑ¢).
ventricular puncture
³ú½ÇõÀÚ(Òàãøô¾ô§).
ventricular remodeling
½É½Ç°³Á¶
ventricular rhythm
½É½ÇÀ²µ¿(ãýãøëÏÔÑ).
ventricular septal defect
½É½ÇÁ߰ݰá¼Õ(ãýãøñḛ́ÌÀáß)
ventricular septal defect
½É½ÇÁ߰ݰá¼Õ(ãýãøñḛ́ÌÀáß).
ventricular septal defect
½É½Ç»çÀ̸·°áÇÔ
ventricular septum
½É½ÇÁß°Ý.
ventricular septum
½É½ÇÁß°Ý(ãýãøñḛ́)
ventricular standstill
½É½ÇÁ¤Áö.
ventricular standstill
½É½ÇÁ¤Áö(ãýãøïÎò)
ventricular strain
½É½Ç±äÀå(ãýãøÑÌíå).
ventricular strain
½É½Ç±äÀå(ãýãøÑÌíå)
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½